Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome

Maria D. Begnami(Hospital de Câncer de Barretos), Fernando Augusto Soares(AC Camargo Hospital)

Journal of Clinical Oncology

June 28, 2011

10.1200/jco.2010.33.6313

Cited by 256

Related Papers

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry

|BMC Cancer|2009|72

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma.

|Blood|2006|39

Immunohistochemical Expression Pattern of Germinal Center and Non-Germinal Center Markers Correlates with Prognosis in Diffuse Large B-Cell Lymphoma.

|Blood|2006|0